Updates and news related to prostate cancer:
Promising Therapy if PSA Rises After Prostate Cancer Surgery
Research shows a promising new option for men who experience rising PSA after a radical prostatectomy.
Focused Ultrasound Controls Prostate Cancer with Fewer Side Effects
Focal therapy using MRI-guided focused ultrasound is safe and effective for men with intermediate-risk prostate cancer who seek to avoid more invasive treatments, according to a study.
Prostate Cancer Outcomes After HIFU Characterized
In a study, 83% of patients who received focal HIFU for localized prostate cancer remained free from radical therapy at 36 months.
Drugs or Active Surveillance for Low-Risk Prostate Cancer?
About 60% of men with low-risk prostate cancer now opt for active surveillance.
Surgery vs Radiation
Uses, benefits and side effects
The Efficacy and Safety of Relugolix vs Leuprolide
HERO study in men with advanced prostate cancer based on baseline BMI
NeuroSAFE Ups Odds of Nerve-Sparing Prostate Cancer Surgery
Neurovascular bundles are spared if intraoperative pathologic examination of tissue adjacent to the bundles following removal of the prostate shows negative surgical margins.
Lynparza Boosts Prostate Cancer Survival
AstraZeneca and Merck's Lynparza won an FDA go-ahead in prostate cancer this past May.
Merck Calls It Quits on Keytruda-Lynparza Combo in Prostate Cancer
The combination of two powerful drugs with excellent clinical track records isn’t necessarily a guarantee for success.
How Realistic is Radical Prostatectomy Without Prior Biopsy?
German case series suggests it may be feasible